ENDENVO Trademark

Trademark Overview


On Tuesday, September 23, 2014, a trademark application was filed for ENDENVO with the United States Patent and Trademark Office. The USPTO has given the ENDENVO trademark a serial number of 86403621. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 10, 2021. This trademark is owned by Glaxo Group Limited. The ENDENVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
endenvo

General Information


Serial Number86403621
Word MarkENDENVO
Filing DateTuesday, September 23, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 10, 2021
Registration Number4743015
Registration DateTuesday, May 26, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, December 10, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, May 26, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 26, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 10, 2015PUBLISHED FOR OPPOSITION
Wednesday, February 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 2, 2015ASSIGNED TO LIE
Tuesday, January 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 8, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 7, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 7, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 18, 2014NOTIFICATION OF PRIORITY ACTION E-MAILED
Thursday, December 18, 2014PRIORITY ACTION E-MAILED
Thursday, December 18, 2014PRIORITY ACTION WRITTEN
Thursday, December 11, 2014ASSIGNED TO EXAMINER
Wednesday, October 1, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 26, 2014NEW APPLICATION ENTERED IN TRAM